Arbor Biotechnologies Stock
Arbor Biotechnologies is a biotechnology company focused on developing next-generation gene editing therapies. They utilize a diverse toolbox of novel gene editors to create treatments for various genetic diseases. Their approach aims to provide functional cures by precisely targeting and modifying specific genes associated with these conditions.
Sign up for SecondMarket™ to view the market and buy or sell Arbor Biotechnologies Stock
Buy + SellArbor Biotechnologies Funding
Sign up to gain insights into Arbor Biotechnologies funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Mar 18, 2025 | Series C | 73.90M | ||
| Oct 29, 2021 | Series B | 215.00M | ||
| Aug 02, 2017 | Series A | 3.37M | ||
| May 19, 2017 | Series A | 12.22M |
See Arbor Biotechnologies Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Arbor Biotechnologies Stock Valuation + Share Prices
View real-time Tape D™ data on Arbor Biotechnologies stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Arbor Biotechnologies Management Team
Chief People Officer
Lee Ann Marchionna
Chief Scientific Officer
John Murphy
CTO
David Cheng
CEO
Devyn Smith
Chief Medical Officer
Dan Ory
COO
Pam Stetkiewicz
Director
David Walt
Arbor Biotechnologies Major Investors
Logos Capital
Ally Bridge Group
Great Point Ventures (GPV)
Kerna Ventures
abrdn Inc
Vertex Pharmaceuticals Incorporated
Piper Heartland Healthcare Capital
T. Rowe Price
Ono Venture Investment
Temasek
Illumina Ventures
Deep Track Capital
Surveyor Capital
TCG X
Section 32
Tao Capital Partners
Ridgeback Capital
ArrowMark Partners
Revelation Partners
Tekla Capital Management LLC
Qatar Investment Authority (QIA)
Woodline Partners LP
ARCH Venture Partners
Learn More About Arbor Biotechnologies Stock
Buy Arbor Biotechnologies Stock
01Arbor Biotechnologies stock does not trade on public stock exchanges. Arbor Biotechnologies stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Arbor Biotechnologies stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Arbor Biotechnologies Stock
02Arbor Biotechnologies Stock does not trade on public stock exchanges. In order to sell Arbor Biotechnologies shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Arbor Biotechnologies Stock Price
03Arbor Biotechnologies does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Arbor Biotechnologies share price and other valuable private market data.
Read more about secondary market private company stock prices:
Arbor Biotechnologies Stock Ticker Symbol
04There is no ticker symbol for Arbor Biotechnologies stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Arbor Biotechnologies Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Arbor Biotechnologies stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Arbor Biotechnologies Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Arbor Biotechnologies stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Arbor Biotechnologies Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Arbor Biotechnologies IPO
08Arbor Biotechnologies is a private company and has not had an IPO. There is currently no Arbor Biotechnologies IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Arbor Biotechnologies IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Arbor Biotechnologies Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
